UNITED THERAPEUTICS Corp 4

Nilda Mesa received 650 shares of United Therapeutics Corp common stock upon vesting of restricted stock units, increasing her direct holdings to 5,678 shares.

On July 9, 2026, insider Nilda Mesa of United Therapeutics Corp had 650 restricted stock units vest, which were converted on a one-for-one basis into 650 shares of common stock at a reported price of $0.00, indicating a routine equity compensation event rather than an open-market transaction. Following this vesting and conversion, Mesa directly owned 5,678 shares of United Therapeutics common stock. As no market price data were provided, the economic value of both the transaction and the post-transaction holdings cannot be precisely determined, but the transaction is best characterized as standard RSU vesting with no sale of shares reported.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001756697-26-000002

Alert Tier

4